Free Trial

Genmab A/S (GMAB) News Today

Genmab A/S logo
$20.59 -0.09 (-0.42%)
As of 09:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

GMAB Latest News

Transactions in Connection with Share Buy-back Program
Genmab A/S Sponsored ADR stock logo
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Acquired by QRG Capital Management Inc.
QRG Capital Management Inc. increased its position in Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) by 213.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 74,847 shares of the company's stock after purchasing an addit
Genmab A/S Sponsored ADR stock logo
GAMMA Investing LLC Boosts Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)
GAMMA Investing LLC lifted its stake in Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) by 1,465.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,482 shares of the company's stock after buying an additiona
Genmab A/S Sponsored ADR stock logo
Park Avenue Securities LLC Takes Position in Genmab A/S (NASDAQ:GMAB)
Park Avenue Securities LLC acquired a new position in shares of Genmab A/S (NASDAQ:GMAB - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 14,108 shares of the company's stock, valued at ap
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered Genmab A/S from a "buy" rating to a "hold" rating in a report on Saturday.
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Given Consensus Rating of "Moderate Buy" by Analysts
Genmab A/S (NASDAQ:GMAB - Get Free Report) has been given an average rating of "Moderate Buy" by the thirteen research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold re
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Downgraded to Hold Rating by Wall Street Zen
Wall Street Zen cut Genmab A/S from a "buy" rating to a "hold" rating in a research report on Friday.
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Shares Gap Down - Should You Sell?
Genmab A/S (NASDAQ:GMAB) Shares Gap Down - What's Next?
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Shares Gap Up - What's Next?
Genmab A/S (NASDAQ:GMAB) Shares Gap Up - Here's What Happened
Why Genmab Stock Smashed It on Monday
Genmab A/S Sponsored ADR stock logo
Legacy Wealth Asset Management LLC Purchases 13,246 Shares of Genmab A/S (NASDAQ:GMAB)
Legacy Wealth Asset Management LLC increased its position in Genmab A/S (NASDAQ:GMAB - Free Report) by 36.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 49,367 shares of the company's stock after acquiring an addition
Genmab A/S Sponsored ADR stock logo
33,010 Shares in Genmab A/S (NASDAQ:GMAB) Bought by Mackenzie Financial Corp
Mackenzie Financial Corp bought a new position in shares of Genmab A/S (NASDAQ:GMAB - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 33,010 shares of the company's stock, value
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Shares Acquired by Squarepoint Ops LLC
Squarepoint Ops LLC lifted its holdings in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 1,235.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 117,507 shares of the company's stock after purchasing an add
Genmab A/S Sponsored ADR stock logo
Employees Retirement System of Texas Invests $1.65 Million in Genmab A/S (NASDAQ:GMAB)
Employees Retirement System of Texas acquired a new position in shares of Genmab A/S (NASDAQ:GMAB - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 78,950 shares of the company's stock, valued at approximate
Genmab A/S Sponsored ADR stock logo
GTS Securities LLC Acquires Shares of 74,356 Genmab A/S (NASDAQ:GMAB)
GTS Securities LLC acquired a new stake in Genmab A/S (NASDAQ:GMAB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 74,356 shares of the company's stock, valued at approximately $1,552,000. A number of ot
Genmab A/S Sponsored ADR stock logo
Bank of America Corp DE Has $9.91 Million Position in Genmab A/S (NASDAQ:GMAB)
Bank of America Corp DE lowered its position in Genmab A/S (NASDAQ:GMAB - Free Report) by 55.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 474,858 shares of the company's stock after selling 579,588
Genmab A/S Sponsored ADR stock logo
Voloridge Investment Management LLC Buys 561,767 Shares of Genmab A/S (NASDAQ:GMAB)
Voloridge Investment Management LLC grew its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 102.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,110,191 shares of the company's stock after purchasing an additional 561
Genmab A/S Sponsored ADR stock logo
Point72 Asset Management L.P. Buys Shares of 88,146 Genmab A/S (NASDAQ:GMAB)
Point72 Asset Management L.P. acquired a new stake in Genmab A/S (NASDAQ:GMAB - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 88,146 shares of the company's stock, valued at approximately $1,840,000. A numbe
Genmab A/S Sponsored ADR stock logo
Quantinno Capital Management LP Buys 66,128 Shares of Genmab A/S (NASDAQ:GMAB)
Quantinno Capital Management LP increased its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 273.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 90,335 shares of the company's stock after purchasing an additional 66,
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Shares Gap Up - Should You Buy?
Genmab A/S (NASDAQ:GMAB) Shares Gap Up - Should You Buy?
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Shares Bought by Two Sigma Advisers LP
Two Sigma Advisers LP grew its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 168.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,653,500 shares of the company's stock after purchasing
Genmab A/S Sponsored ADR stock logo
Two Sigma Investments LP Raises Stake in Genmab A/S (NASDAQ:GMAB)
Two Sigma Investments LP raised its holdings in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 122.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,706,364 shares of the company's stock after acquiring an
Genmab A/S Sponsored ADR stock logo
OMERS ADMINISTRATION Corp Invests $378,000 in Genmab A/S (NASDAQ:GMAB)
OMERS ADMINISTRATION Corp purchased a new stake in shares of Genmab A/S (NASDAQ:GMAB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 18,100 shares of the company's stock, valued at approximately $378,000
Genmab AS ADR GMAB
Genmab A/S Sponsored ADR stock logo
Tema Etfs LLC Acquires New Position in Genmab A/S (NASDAQ:GMAB)
Tema Etfs LLC acquired a new stake in Genmab A/S (NASDAQ:GMAB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 58,935 shares of the company's stock, valued at approximately $1,230,000. A
Genmab A/S Sponsored ADR stock logo
Genmab A/S (NASDAQ:GMAB) Receives Average Recommendation of "Moderate Buy" from Analysts
Genmab A/S (NASDAQ:GMAB - Get Free Report) has earned a consensus rating of "Moderate Buy" from the thirteen analysts that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating a
Genmab A/S Sponsored ADR stock logo
BNP Paribas Financial Markets Invests $2.55 Million in Genmab A/S (NASDAQ:GMAB)
BNP Paribas Financial Markets bought a new position in Genmab A/S (NASDAQ:GMAB - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 122,373 shares of the company's stock, valued at approximately $2,554,000. A number of ot
Genmab A/S Sponsored ADR stock logo
Northern Trust Corp Increases Stock Position in Genmab A/S (NASDAQ:GMAB)
Northern Trust Corp boosted its stake in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 18.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 599,381 shares of the company's stock after buying an
Genmab A/S Sponsored ADR stock logo
Point72 Hong Kong Ltd Takes Position in Genmab A/S (NASDAQ:GMAB)
Point72 Hong Kong Ltd purchased a new stake in Genmab A/S (NASDAQ:GMAB - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 43,671 shares of the company's stock, valued at approximately $911,000. A number o
Genmab A/S Sponsored ADR stock logo
Dimensional Fund Advisors LP Sells 24,894 Shares of Genmab A/S (NASDAQ:GMAB)
Dimensional Fund Advisors LP lessened its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 35.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 45,615 shares of the company's stock after selling 24,894 shares during the period. Dimensi
Get Genmab A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter.

GMAB Media Mentions By Week

GMAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GMAB
News Sentiment

0.88

0.62

Average
Medical
News Sentiment

GMAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GMAB Articles
This Week

6

6

GMAB Articles
Average Week

Get Genmab A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GMAB) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners